Advanced glycation end-products and methionine sulphoxide in skin collagen of patients with type 1 diabetes

[1]  S. Genuth,et al.  Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes. , 2005, Diabetes.

[2]  J. Williamson,et al.  Reactive Carbonyls and Polyunsaturated Fatty Acids Produce a Hydroxyl Radical-like Species , 2005, Journal of Biological Chemistry.

[3]  P. Schieberle,et al.  Labeling Studies on the Formation Pathway of Nε‐Carboxymethyllysine in Maillard‐type Reactions , 2005 .

[4]  D. Ng.  The role of statins in oxidative stress and cardiovascular disease. , 2005, Current drug targets. Cardiovascular & haematological disorders.

[5]  M. Runge,et al.  Oxidative Stress and Vascular Disease , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[6]  Richard T. Lee,et al.  Hyperglycemia Promotes Oxidative Stress through Inhibition of Thioredoxin Function by Thioredoxin-interacting Protein* , 2004, Journal of Biological Chemistry.

[7]  B. Szwergold,et al.  Enzymatic deglycation--a new paradigm or an epiphenomenon? , 2003, Biochemical Society transactions.

[8]  H. Kotani,et al.  Vitamin D3 up-regulated protein-1 regulates collagen expression in mesangial cells. , 2003, Kidney international.

[9]  D. Lackland,et al.  Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia. , 2003, Diabetes care.

[10]  M. Nangaku,et al.  Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms. , 2002, Journal of the American Society of Nephrology : JASN.

[11]  T. Lyons.  Glycation, Carbonyl Stress, EAGLEs, and the Vascular Complications of Diabetes , 2002, Seminars in vascular medicine.

[12]  M. Brownlee.  Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[13]  A. Jenkins,et al.  Isotope dilution gas chromatography/mass spectrometry method for the determination of methionine sulfoxide in protein. , 2001, Analytical chemistry.

[14]  S. Heinemann,et al.  Regulation of cell function by methionine oxidation and reduction , 2001, The Journal of physiology.

[15]  S. Genuth,et al.  Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Contro , 1999, Diabetes.

[16]  J. Baynes,et al.  Immunohistochemical and ELISA Assays for Biomarkers of Oxidative Stress in Aging and Disease a , 1998, Annals of the New York Academy of Sciences.

[17]  J. Baynes,et al.  Chemical modification of proteins by methylglyoxal. , 1998, Cellular and molecular biology.

[18]  T. Lyons,et al.  Age-dependent increase in ortho-tyrosine and methionine sulfoxide in human skin collagen is not accelerated in diabetes. Evidence against a generalized increase in oxidative stress in diabetes. , 1997, The Journal of clinical investigation.

[19]  J. Baynes,et al.  N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. , 1997, The Biochemical journal.

[20]  David H. Williams,et al.  Phosphorylation of SLP-76 by the ZAP-70 Protein-tyrosine Kinase Is Required for T-cell Receptor Function* , 1996, The Journal of Biological Chemistry.

[21]  T. Lyons,et al.  The Advanced Glycation End Product, N-(Carboxymethyl)lysine, Is a Product of both Lipid Peroxidation and Glycoxidation Reactions (*) , 1996, The Journal of Biological Chemistry.

[22]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[23]  L. L. Moore,et al.  Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy. , 1993, The Journal of clinical investigation.

[24]  T. Lyons,et al.  Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. , 1993, The Journal of clinical investigation.

[25]  L. L. Moore,et al.  Relationship Between Glycemic Control and Collagen-Linked Advanced Glycosylation End Products in Type I Diabetes , 1993, Diabetes Care.

[26]  T. Lyons,et al.  Accumulation of Maillard Reaction Products in Skin Collagen in Diabetes and Aging a , 1992, Annals of the New York Academy of Sciences.

[27]  V. Monnier,et al.  Pentosidine Formation in Skin Correlates With Severity of Complications in Individuals With Long-Standing IDDM , 1992, Diabetes.

[28]  J. McMurray,et al.  Antioxidant Effects of Angiotensin-Converting Enzyme (ACE) Inhibitors: Free Radical and Oxidant Scavenging are Sulfhydryl Dependent, but Lipid Peroxidation is Inhibited by Both Sulfhydryl- and Nonsulfhydryl-Containing ACE Inhibitors , 1992, Journal of cardiovascular pharmacology.

[29]  J. Baynes,et al.  Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. , 1991, The Journal of biological chemistry.

[30]  T. Lyons,et al.  Decrease in skin collagen glycation with improved glycemic control in patients with insulin-dependent diabetes mellitus. , 1991, The Journal of clinical investigation.

[31]  T. Lyons,et al.  Age-dependent accumulation of N epsilon-(carboxymethyl)lysine and N epsilon-(carboxymethyl)hydroxylysine in human skin collagen. , 1991, Biochemistry.

[32]  S. Genuth,et al.  Diabetes Control and Complications Trial (DCCT): Results of Feasibility Study. The DCCT Research Group , 1987, Diabetes Care.

[33]  S. Oikawa,et al.  Inhibitory effects of amlodipine and fluvastatin on the deposition of advanced glycation end products in aortic wall of cholesterol and fructose-fed rabbits. , 2006, Biological & pharmaceutical bulletin.

[34]  T. Lyons,et al.  Glycation and Glycoxidation in Diabetic Vascular Disease , 2000 .

[35]  W. Tamborlane,et al.  Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. , 1999, Diabetes care.

[36]  The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial. , 1995, Archives of ophthalmology.

[37]  J. Affeldt,et al.  The feasibility study , 2019, The Information System Consultant’s Handbook.